BIO-key International reports Q3 revenue of $1.55 million

Reuters2025-11-14

BIO-key International reports Q3 revenue of $1.55 million

BIO-key International Inc. reported total revenues of $1.6 million for the third quarter of 2025, compared to $2.1 million in the same period last year. The year-over-year decrease was mainly due to two large orders in Q3 2024 totaling approximately $665,000. As of September 30, 2025, total current assets were $2.2 million, including $1.1 million in cash and cash equivalents, $0.5 million in accounts receivable, and $0.6 million in inventory. The company issued a $1.0 million senior secured promissory note on September 30, 2025. Subsequent to the quarter, on October 27, 2025, BIO-key raised $3.1 million in gross proceeds from a warrant exercise agreement with an existing institutional investor. Business developments included a significant new deployment of biometric and multi-factor authentication technologies for a Middle East defense sector organization and additional hardware and license orders totaling $134,000 in Q4 2025 to a foreign defense ministry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2583050575?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-14 20:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583050575","market":"us","top_or_hot":-1,"title":"BIO-key International reports Q3 revenue of $1.55 million","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      BIO-key International reports Q3 revenue of $1.55 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        BIO-key International Inc. reported total revenues of $1.6 million for the third quarter of 2025, compared to $2.1 million in the same period last year. The year-over-year decrease was mainly due to two large orders in Q3 2024 totaling approximately $665,000. As of September 30, 2025, total current assets were $2.2 million, including $1.1 million in cash and cash equivalents, $0.5 million in accounts receivable, and $0.6 million in inventory. The company issued a $1.0 million senior secured promissory note on September 30, 2025. Subsequent to the quarter, on October 27, 2025, BIO-key raised $3.1 million in gross proceeds from a warrant exercise agreement with an existing institutional investor. Business developments included a significant new deployment of biometric and multi-factor authentication technologies for a Middle East defense sector organization and additional hardware and license orders totaling $134,000 in Q4 2025 to a foreign defense ministry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BIO-key International reports Q3 revenue of $1.55 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBIO-key International reports Q3 revenue of $1.55 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-14 20:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      BIO-key International reports Q3 revenue of $1.55 million\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        BIO-key International Inc. reported total revenues of $1.6 million for the third quarter of 2025, compared to $2.1 million in the same period last year. The year-over-year decrease was mainly due to two large orders in Q3 2024 totaling approximately $665,000. As of September 30, 2025, total current assets were $2.2 million, including $1.1 million in cash and cash equivalents, $0.5 million in accounts receivable, and $0.6 million in inventory. The company issued a $1.0 million senior secured promissory note on September 30, 2025. Subsequent to the quarter, on October 27, 2025, BIO-key raised $3.1 million in gross proceeds from a warrant exercise agreement with an existing institutional investor. Business developments included a significant new deployment of biometric and multi-factor authentication technologies for a Middle East defense sector organization and additional hardware and license orders totaling $134,000 in Q4 2025 to a foreign defense ministry.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BKYI","symbol_name":"BIO-key International, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251114:nNDL79wRDN:1","article_id":"2583050575","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583050575","pubTimestamp":1763124462,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BIO-key International Inc. reported total revenues of $1.6 million for the third quarter of 2025, compared to $2.1 million in the same period last year. The year-over-year decrease was mainly due to two large orders in Q3 2024 totaling approximately $665,000. As of September 30, 2025, total current assets were $2.2 million, including $1.1 million in cash and cash equivalents, $0.5 million in accounts receivable, and $0.6 million in inventory. The company issued a $1.0 million senior secured promissory note on September 30, 2025. Subsequent to the quarter, on October 27, 2025, BIO-key raised $3.1 million in gross proceeds from a warrant exercise agreement with an existing institutional investor. Business developments included a significant new deployment of biometric and multi-factor authentication technologies for a Middle East defense sector organization and additional hardware and license orders totaling $134,000 in Q4 2025 to a foreign defense ministry.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BKYI":"BIO-key International, Inc.","BK4097":"系统软件"},"translate_title":"BIO-key International报告第三季度收入为155万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BKYI":0.9},"content_text":"BIO-key International reports Q3 revenue of $1.55 million\n    \n\n        BIO-key International Inc. reported total revenues of $1.6 million for the third quarter of 2025, compared to $2.1 million in the same period last year. The year-over-year decrease was mainly due to two large orders in Q3 2024 totaling approximately $665,000. As of September 30, 2025, total current assets were $2.2 million, including $1.1 million in cash and cash equivalents, $0.5 million in accounts receivable, and $0.6 million in inventory. The company issued a $1.0 million senior secured promissory note on September 30, 2025. Subsequent to the quarter, on October 27, 2025, BIO-key raised $3.1 million in gross proceeds from a warrant exercise agreement with an existing institutional investor. Business developments included a significant new deployment of biometric and multi-factor authentication technologies for a Middle East defense sector organization and additional hardware and license orders totaling $134,000 in Q4 2025 to a foreign defense ministry.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief on November 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2583050575","isCrawlerRequest":true}